|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
EBSCO_ocn989513174 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
170608t20172017nyu ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d EBLCP
|d OCLCF
|d IGB
|d AUW
|d BTN
|d MHW
|d INTCL
|d SNK
|d G3B
|d S8I
|d S8J
|d STF
|d D6H
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9781536110586
|q (electronic bk.)
|
| 020 |
|
|
|a 1536110582
|q (electronic bk.)
|
| 020 |
|
|
|z 9781536110388
|
| 035 |
|
|
|a (OCoLC)989513174
|
| 050 |
|
4 |
|a RC267
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.99/4
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Horizons in cancer research.
|n Volume 67 /
|c Hiroto S. Watanabe, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Science Publishers, Inc.,
|c [2017]
|
| 264 |
|
4 |
|c Ã2017
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed June 9, 2017).
|
| 505 |
0 |
|
|a Preface; Chapter 1; miRNA as a Novel Diagnostic and Predictive Biomarker in Human Cancers; 1. Introduction; 1.1. miRNA as Gene Regulator; 1.1.1. Down-Regulation of Gene by miRNA; 1.1.2. miRNA Mediated Upregulation of Gene; 1.2. miRNA Biogenesis; 1.3. Different miRNA Families and Their Functions; 1.3.1. miRNA-200 Family; 1.3.2. Let-7 Family; 1.3.3. miR-34 Family; 1.3.4. miR-126 and miR-335; 1.3.5. miR-10b; 1.3.6. miR-21; 1.3.7. miR-373 and miR-520c; 1.3.8. miR-199/214 Family; 1.3.9. miR-92a; 1.3.10. miR-100; 1.4. miRNA Associated with Carcinogenesis
|
| 505 |
8 |
|
|a 2. miRNA Associated with Gynecological Malignancies2.1. miRNA in Ovarian Cancer; 2.2. miRNA in Endometrial Cancer; 2.3. miRNA in Cervical Cancer; 2.4. miRNA in Vulvar Cancer; 3. miRNA as Diagnostic and Predictive Biomarker in Cancer; 3.1. miRNA in Ovarian Cancer Prediction; 3.2. miRNA in Breast Cancer Prediction; 4. Advantages of miRNA as an Epigenetic Marker in Cancer Diagnostics; Conclusion; References; Chapter 2; The Deregulated Expression and Function of S100 Proteins in Cancer Cells; Abstract; Introduction; Genes for S100 Proteins and Structure of S100 Proteins
|
| 505 |
8 |
|
|a Functions of S100 ProteinsThe Role of the S100 Proteins in Metastatic Growth; Role of S100A8 and S100A9 in Pathogenesis of Myelodysplastic Syndrome with Deletion on Long Arm of Chromosome 5; Role of S100A8 and S100A9 in MDS; Inhibition of S100 Proteins; Conclusions and Perspectives; Acknowledgments; References; Chapter 3; Recent Perspectives in the Management of Nasopharyngeal Carcinoma; Abstract; 1. Introduction; 2. Staging; 3. Early-Stage Disease; 4. Locoregionally Advanced Nasopharyngeal Carcinoma; 4.1. Concurrent Chemoradiation
|
| 505 |
8 |
|
|a 4.2. Induction Chemotherapy plus Concurrent Chemoradiotherapy4.3. Inhibition of EGFR (Cetuximab) in Combination with Chemoradiation; 5. Local Residual Nasopharyngeal Disease; 6. Recurrent and Metastatic Disease; 6.1. Surgery; 6.2. Radiation; 6.3. Chemotherapy; 6.4. Molecular-Targeted Therapies; 6.5. Therapeutic Vaccine Targeting Epstein-Barr Virus (EBV); 7. Evolution; Conclusion; References; Chapter 4; The State-of-the-Art Therapeutic Human Papillomavirus Vaccine; Abstract; Introduction; Historical Notes: From Pap Test to Vaccines; HPV Molecular Biology and Virology
|
| 505 |
8 |
|
|a HPV Immunology and VaccinesConclusion; References; Index; Blank Page
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Cancer
|x Research.
|
| 650 |
|
0 |
|a Cancer
|x Treatment.
|
| 650 |
|
6 |
|a Cancer
|x Recherche.
|
| 650 |
|
6 |
|a Cancer
|x Traitement.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Cancer
|x Research.
|2 fast
|0 (OCoLC)fst00845497
|
| 650 |
|
7 |
|a Cancer
|x Treatment.
|2 fast
|0 (OCoLC)fst00845538
|
| 700 |
1 |
|
|a Watanabe, Hiroto S.,
|e editor.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1530919
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4871584
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1530919
|
| 994 |
|
|
|a 92
|b IZTAP
|
